BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Head and neck cancer AND RHOH, TTF, 399, ENSG00000168421, ARHH, RhoH
571 results:

  • 1. The Prognostic Immune and Nutritional Indices Are Independent Prognostic Factors for Esophageal cancer Patients Who Receive Curative Treatment.
    Aoyama T; Hashimoto I; Maezawa Y; Hara K; Kato A; Kazama K; Tamagawa A; Cho H; Nakazono M; Numata M; Kawahara S; Oshima T; Saito A; Yukawa N
    Anticancer Res; 2024 May; 44(5):2185-2192. PubMed ID: 38677744
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Anaplastic and poorly differentiated thyroid carcinomas: genetic evidence of high-grade transformation from differentiated thyroid carcinoma.
    Gu H; Wang J; Ran W; Li G; Hu S; Zhao H; Wang X; Wang J
    J Pathol Clin Res; 2024 Mar; 10(2):e356. PubMed ID: 38602501
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Cytomorphology of monomorphic spindle epithelial tumor with thymus-like elements: A case with local recurrence after subtotal resection.
    Arshia A; Balikani L; Booth CN
    Diagn Cytopathol; 2024 Jun; 52(6):E134-E144. PubMed ID: 38520309
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Beta-defensin index: A functional biomarker for oral cancer detection.
    Ghosh SK; Man Y; Fraiwan A; Waters C; McKenzie C; Lu C; Pfau D; Kawsar H; Bhaskaran N; Pandiyan P; Jin G; Briggs F; Zender CC; Rezaee R; Panagakos F; Thuener JE; Wasman J; Tang A; Qari H; Wise-Draper T; McCormick TS; Madabhushi A; Gurkan UA; Weinberg A
    Cell Rep Med; 2024 Mar; 5(3):101447. PubMed ID: 38442713
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Rehabilitation Interventions in head and 399FF">neck cancer: A Scoping Review.
    Cheng JT; Ramos Emos M; Leite V; Capozzi L; Woodrow LE; Gutierrez C; Ngo-Huang A; Krause KJ; Parke SC; Langelier DM
    Am J Phys Med Rehabil; 2024 Mar; 103(3S Suppl 1):S62-S71. PubMed ID: 38364033
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Efficacy and safety of neoadjuvant sintilimab in combination with FLOT chemotherapy in patients with HER2-negative locally advanced gastric or gastroesophageal junction adenocarcinoma: an investigator-initiated, single-arm, open-label, phase II study.
    Li N; Li Z; Fu Q; Zhang B; Zhang J; Wan XB; Lu CM; Wang JB; Deng WY; Ma YJ; Bie LY; Wang MY; Li J; Xia QX; Wei C; Luo SX
    Int J Surg; 2024 Apr; 110(4):2071-2084. PubMed ID: 38320099
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Late age at first birth is a protective factor for oesophageal cancer and gastro-oesophageal reflux: the evidence from the genetic study.
    Su Y; Xu Y; Hu Y; Chang Y; Wu F; Yang M; Peng Y
    Front Endocrinol (Lausanne); 2023; 14():1329763. PubMed ID: 38288469
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Impact of intraoperative fluid management on postoperative complications in patients undergoing minimally invasive esophagectomy for esophageal cancer: a retrospective single-center study.
    Takahashi M; Toyama H; Takahashi K; Kaiho Y; Ejima Y; Yamauchi M
    BMC Anesthesiol; 2024 Jan; 24(1):29. PubMed ID: 38238681
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Low-Dose Radiation Yields Lower Rates of Pathologic Response in Esophageal cancer Patients.
    Mantziari S; Farinha HT; Messier M; Winiker M; Allemann P; Ozsahin EM; Demartines N; Piessen G; Schäfer M
    Ann Surg Oncol; 2024 Apr; 31(4):2499-2508. PubMed ID: 38198002
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Neoadjuvant and adjuvant pembrolizumab plus chemotherapy in locally advanced gastric or gastro-oesophageal cancer (KEYNOTE-585): an interim analysis of the multicentre, double-blind, randomised phase 3 study.
    Shitara K; Rha SY; Wyrwicz LS; Oshima T; Karaseva N; Osipov M; Yasui H; Yabusaki H; Afanasyev S; Park YK; Al-Batran SE; Yoshikawa T; Yanez P; Dib Bartolomeo M; Lonardi S; Tabernero J; Van Cutsem E; Janjigian YY; Oh DY; Xu J; Fang X; Shih CS; Bhagia P; Bang YJ;
    Lancet Oncol; 2024 Feb; 25(2):212-224. PubMed ID: 38134948
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Contribution of public oral pathology services to the diagnosis of oral and oropharyngeal cancer in Brazil.
    Louredo BVR; Curado MP; Penafort PVM; de Arruda JAA; Abreu LG; Mesquita RA; Pinto-Júnior DDS; Abrahão AC; Andrade BAB; Agostini M; Moraes RM; Anbinder AL; Dourado PHS; Santos TCRBD; Pires FR; Bordignon NCT; Gondak RO; DE Oliveira MG; Carrard VC; Martins MD; Sousa-Neto SS; Arantes DAC; Mendonça EF; Cieslak-Sanches SR; Antunes DM; Amaral-Silva GKD; Manieri PR; Ramalho LMP; Dos Santos JN; Leonel ACLDS; Perez DEDC; Verheul HCCRS; Barroso KMA; Rodrigues FLS; Gonzaga AKG; Fernandes RR; DE Souza LB; Souza LL; Pontes FSC; Pontes HAR; Silva CA; Câmara J; Libório-Kimura TN; Santos-Silva AR; Lopes MA; Almeida OP; Romañach MJ; Vargas PA
    Braz Oral Res; 2023; 37():e126. PubMed ID: 38126470
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Liver Mass as First-Time Diagnosis of Sarcomatoid Anaplastic Thyroid Carcinoma: A Rare Malignancy Presenting at an Unexpected Body Site.
    Kamashki A; Rivera M; Sturgis CD
    Am J Case Rep; 2023 Dec; 24():e941838. PubMed ID: 38041397
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [Sclerosing mucoepidermoid carcinoma with eosinophilia of thyroid gland].
    Abrosimov AY; Bondarenko EV; Pastuhova DA; Beloshitsky ME
    Arkh Patol; 2023; 85(6):47-51. PubMed ID: 38010638
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Deep learning-based outcome prediction using PET/CT and automatically predicted probability maps of primary tumor in patients with oropharyngeal cancer.
    De Biase A; Ma B; Guo J; van Dijk LV; Langendijk JA; Both S; van Ooijen PMA; Sijtsema NM
    Comput Methods Programs Biomed; 2024 Feb; 244():107939. PubMed ID: 38008678
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Prognostic value of the fibrinogen albumin ratio index (FARI) in nasopharyngeal carcinoma patients undergoing radiotherapy.
    Deng C; Zhang S; Ling J; Chen Z; Feng Y; Xie Y; Liu X; Hu C; Hou T
    Sci Rep; 2023 Nov; 13(1):20630. PubMed ID: 37996660
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Novel approach of prophylactic radiation to reduce toxicities comparing 2-step40 with 56-Gy simultaneous integrated boost intensity-modulated radiation therapy for locally advanced squamous cell carcinoma of the head and 399FF">neck, an intergroup phase III trial (JCOG1912, NEW BRIDGE).
    Yokota T; Zenda S; Kodaira T; Kiyota N; Fujimoto Y; Wasano K; Takahashi R; Mizowaki T; Homma A; Sasaki K; Machida R; Sekino Y; Fukuda H; ;
    BMC Cancer; 2023 Nov; 23(1):1068. PubMed ID: 37932681
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Clinical Outcomes of Preserving Bronchial Arteries During Radical Esophagectomy: A Propensity-Score Matched Analysis.
    Fujisawa K; Ohkura Y; Ueno M; Ogawa Y; Shimoyama H; Haruta S; Udagawa H
    Ann Surg Oncol; 2024 Feb; 31(2):827-837. PubMed ID: 37882931
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Trajectories of fear of progression in nasopharyngeal carcinoma patients receiving proton and heavy ion therapy.
    Zheng M; Wang S; Zhu Y; Wan H
    Support Care Cancer; 2023 Oct; 31(12):630. PubMed ID: 37843679
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Team-Based Surgical Approach to head and 399FF">neck Microvascular Free Flap Reconstruction.
    Yalamanchi P; Peddireddy NS; McMichael B; Keilin C; Casper KA; Malloy KM; Moyer JS; Prince MEP; Rosko AJ; Stucken CL; Spector ME; Chinn SB
    JAMA Otolaryngol Head Neck Surg; 2023 Nov; 149(11):1021-1026. PubMed ID: 37796525
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Validation of CT-Based Risk Stratification System for Lymph Node Metastasis in Patients With Thyroid cancer.
    Roh YH; Chung SR; Baek JH; Choi YJ; Sung TY; Song DE; Kim TY; Lee JH
    Korean J Radiol; 2023 Oct; 24(10):1028-1037. PubMed ID: 37793671
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 29.